Roberta Sartori
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Author Correction: Impaired cAMP-PKA-CREB1 signalling drives mitochondrial dysfunction in skeletal muscle during cancer cachexia.
Journal: Nature metabolism
Published: September 05, 2026
Chemotherapy induces tissue NAD + loss, and downregulation of NAD + biosynthetic enzyme Nrk2 marks muscle wasting.
Journal: bioRxiv : the preprint server for biology
Published: July 29, 2026
Human neuromuscular organoids mimic cancer-induced muscle cachexia.
Journal: Cell reports methods
Published: October 01, 2025
Targeting senescence induced by age or chemotherapy with a polyphenol-rich natural extract improves longevity and healthspan in mice.
Journal: Nature aging
Published: June 11, 2023
FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy.
Journal: Cell reports. Medicine
Published: February 22, 2023
C16ORF70/MYTHO promotes healthy aging in C.elegans and prevents cellular senescence in mammals.
Journal: The Journal of clinical investigation
Published: September 27, 2022
C-terminal agrin fragment as a biomarker of muscle wasting and weakness: a narrative review.
Journal: Journal of cachexia, sarcopenia and muscle
Published: September 21, 2022
NAD+ repletion with niacin counteracts cancer cachexia.
Journal: Nature communications
Published: July 17, 2022
MYTHO is a novel regulator of skeletal muscle autophagy and integrity.
Journal: Nature communications
Published: June 13, 2022
Plasma proteome profiling of healthy subjects undergoing bed rest reveals unloading-dependent changes linked to muscle atrophy.
Journal: Journal of cachexia, sarcopenia and muscle
Published: June 12, 2022
The ERG1A K+ Channel Is More Abundant in Rectus abdominis Muscle from Cancer Patients Than that from Healthy Humans.
Journal: Diagnostics (Basel, Switzerland)
Published: August 27, 2021
Last Updated: 09/26/2026